François Lamothe

1.4k total citations · 1 hit paper
16 papers, 1.0k citations indexed

About

François Lamothe is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, François Lamothe has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in François Lamothe's work include HIV/AIDS Research and Interventions (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Streptococcal Infections and Treatments (4 papers). François Lamothe is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Streptococcal Infections and Treatments (4 papers). François Lamothe collaborates with scholars based in Canada and United States. François Lamothe's co-authors include Anne–Marie Bourgault, Vivian G. Loo, Louise Poirier, Baldwin Toye, Nandini Dendukuri, Sophie Michaud, Nathalie Turgeon, Claire Béliveau, Paul Brassard and Rodica Gilca and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

François Lamothe

16 papers receiving 998 citations

Hit Papers

Host and Pathogen Factors for Clostridium difficile Infec... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Lamothe Canada 13 811 590 209 176 107 16 1.0k
Michael Mostert Italy 19 464 0.6× 504 0.9× 160 0.8× 99 0.6× 485 4.5× 39 1.4k
L. Lanthier Canada 11 645 0.8× 613 1.0× 183 0.9× 199 1.1× 121 1.1× 19 1.1k
Chris A. Gentry United States 15 324 0.4× 327 0.6× 118 0.6× 90 0.5× 41 0.4× 40 682
JohnG. Bartlett United States 5 416 0.5× 271 0.5× 127 0.6× 84 0.5× 43 0.4× 5 597
Claire Nour Abou Chakra Canada 15 624 0.8× 641 1.1× 131 0.6× 224 1.3× 100 0.9× 28 998
Pierre Bulpa Belgium 12 1.0k 1.3× 919 1.6× 187 0.9× 86 0.5× 59 0.6× 28 1.6k
Tom Marrie Canada 14 107 0.1× 464 0.8× 68 0.3× 181 1.0× 69 0.6× 23 1.1k
Adriana M. Rueda United States 14 205 0.3× 631 1.1× 62 0.3× 76 0.4× 115 1.1× 20 980
Elena Múñez Spain 17 540 0.7× 373 0.6× 83 0.4× 173 1.0× 73 0.7× 93 923
Michael R. Driks United States 8 279 0.3× 466 0.8× 326 1.6× 151 0.9× 54 0.5× 10 868

Countries citing papers authored by François Lamothe

Since Specialization
Citations

This map shows the geographic impact of François Lamothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Lamothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Lamothe more than expected).

Fields of papers citing papers by François Lamothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Lamothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Lamothe. The network helps show where François Lamothe may publish in the future.

Co-authorship network of co-authors of François Lamothe

This figure shows the co-authorship network connecting the top 25 collaborators of François Lamothe. A scholar is included among the top collaborators of François Lamothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Lamothe. François Lamothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kong, Ling Yuan, Nandini Dendukuri, Ian Schiller, et al.. (2015). Predictors of asymptomatic Clostridium difficile colonization on hospital admission. American Journal of Infection Control. 43(3). 248–253. 32 indexed citations
2.
Loo, Vivian G., Anne–Marie Bourgault, Louise Poirier, et al.. (2011). Host and Pathogen Factors for Clostridium difficile Infection and Colonization. New England Journal of Medicine. 365(18). 1693–1703. 603 indexed citations breakdown →
3.
Bourgault, Anne–Marie, et al.. (2006). In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Quebec, Canada. Antimicrobial Agents and Chemotherapy. 50(10). 3473–3475. 78 indexed citations
4.
Makedonas, George, Julie Bruneau, Michel Alary, et al.. (2005). Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.. PubMed. 19(3). 251–9. 15 indexed citations
5.
Boileau, Cathérine, et al.. (2005). A Prognostic Model for HIV Seroconversion Among Injection Drug Users as a Tool for Stratification in Clinical Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(4). 489–495. 21 indexed citations
6.
Bruneau, Julie, Susan B. Brogly, Mark Tyndall, François Lamothe, & Eduardo L. Franco. (2004). Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction. 99(6). 727–737. 42 indexed citations
7.
Brogly, Susan B., Julie Bruneau, François Lamothe, Jean Vincelette, & Eduardo L. Franco. (2002). HIV-Positive Notification and Behavior Changes in Montreal Injection Drug Users. AIDS Education and Prevention. 14(1). 17–28. 16 indexed citations
8.
Makedonas, George, Julie Bruneau, Henry Lin, et al.. (2002). HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. AIDS. 16(12). 1595–1602. 28 indexed citations
9.
Bourgault, Anne–Marie, et al.. (1999). Should all stool specimens be routinely tested for Clostridium difficile?. Clinical Microbiology and Infection. 5(4). 219–223. 7 indexed citations
10.
Labbé, Annie‐Claude, et al.. (1999). Trends in Antimicrobial Resistance among Clinical Isolates of the Bacteroides fragilis Group from 1992 to 1997 in Montreal, Canada. Antimicrobial Agents and Chemotherapy. 43(10). 2517–2519. 26 indexed citations
11.
Bourgault, Anne–Marie & François Lamothe. (1997). Update on Pan‐American Activities in the Field of Anaerobes: Canada. Clinical Infectious Diseases. 25(s2). S237–S240. 2 indexed citations
12.
Bourgault, Anne–Marie, et al.. (1997). Fusobacterium Bacteremia: Clinical Experience with 40 Cases.. Clinical Infectious Diseases. 25(s2). S181–S183. 44 indexed citations
13.
Lauzon, Pierre, et al.. (1994). Illicit use of methadone among IV drug users in Montreal. Journal of Substance Abuse Treatment. 11(5). 457–461. 35 indexed citations
14.
Butterworth, Roger F., et al.. (1991). Thiamine deficiency and wernicke's encephalopathy in AIDS. Metabolic Brain Disease. 6(4). 207–212. 71 indexed citations
15.
Malouin, François & François Lamothe. (1987). The role of β-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group. Canadian Journal of Microbiology. 33(3). 262–266. 11 indexed citations
16.
Bourgault, Anne–Marie & François Lamothe. (1986). In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new β-lactam agents against species of the Bacteroides fragilis group. Journal of Antimicrobial Chemotherapy. 17(5). 593–603. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026